SWOT Analysis

Running head: SWOT ANALYSIS 1
SWOT ANALYSIS

Running head: SWOT ANALYSIS
Strengths
The international investments were attracted
with the assistance of the dynamic
government policy and the guidelines.
Improving nearby assembling principles,
with a promise of the biotech advancement is
also one of the strength of the clinics in the
Malaysia.
Due to the acceleration of the medical market
in the recent years in Malaysia, there is a
wide range of the competition (Ahmadi,
Ibrahim & Nilashi, 2015).
Due to the centralized system the clinics in
Malaysia are able to cater the customers with
new services.
Due to the non-presence of the controlling
prices in the private sector the clinics in
Malaysia are able to flourish more.
Sizeable generics showcase, given low
patient buying power and lax patent laws
Endorsing and administering by and by
managed by general professionals, boosting
in general estimations of the medicine
showcase
OTC and generics markets are set to become
emphatically throughout the following nine
to ten years down the line.
Weakness
With the strength comes the weakness where
the law for the lax patients is constantly
below the belt and there seems no
improvement.
Due to the local manufacturing the clinics are
giving the low quality and inexpensive
medicines to the customers.
Late change went for expanding
nonexclusive item improvement exacerbating
activity conditions for multinationals
Severe government medicate evaluating
strategy vigorously one-sided towards nearby
medication makers
Market dependent on imports, especially at
the hey tech end of scale, influencing
government funds
The innovations are less and in this
competitive world the diversification is what
the clinics lack in Malaysia
The lack of the promotional activities is also
one of the critical weakness, unlike in
Thailand and India (Abolfazli, et al 2015).
Opportunities
Medical tourism comprises of the clinics and
hospitals as well. Therefore with the correct
policies and the procedures the market of the
clinics can grow.
Malaysia tends to become one of the popular
subjects in the field of the medicines and
tourism.
ASEAN harmonization empowering the
appropriation of Western administrative
models and the improvement of intra-
territorial exchange (Risso-Gill, et al 2015).
Threats
The presence of the counterfeit drug centre
could lead to the potential threats for the
clinic market.
Severe government medicated evaluating
strategy are adopted vigorously only from
one-sided towards nearby medication makers.
This brings the gap between the medicine
makers and the clinics (Teh, et al 2015).
Market dependent on imports, especially at
the high tech end of scale, influencing
government funds and the cost of the
medicines.